<bill session="116" type="h" number="6660" updated="2023-01-11T13:43:02Z">
  <state datetime="2020-05-01">REFERRED</state>
  <status>
    <introduced datetime="2020-05-01"/>
  </status>
  <introduced datetime="2020-05-01"/>
  <titles>
    <title type="display">LOSS Act of 202</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to require the holders of approved applications for drugs to conduct a risk assessment to identify and evaluate risks to their supply chain and develop, maintain, and implement risk mitigation plans to address such risks, and for other purposes.</title>
    <title type="short" as="introduced">Limit Ongoing Shortages and Stabilize Supply Act of 2020</title>
    <title type="short" as="introduced">LOSS Act of 202</title>
  </titles>
  <sponsor bioguide_id="B001303"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2020-05-01"/>
    <cosponsor bioguide_id="H001081" joined="2020-06-11"/>
    <cosponsor bioguide_id="J000032" joined="2020-05-12"/>
    <cosponsor bioguide_id="K000386" joined="2020-05-12"/>
  </cosponsors>
  <actions>
    <action datetime="2020-05-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-05-01" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-13T14:21:09Z" status="Introduced in House">Limit Ongoing Shortages and Stabilize Supply Act of 2020 or the LOSS Act of 2020 

This bill addresses drug shortages, including by requiring drug manufacturers to conduct risk assessments and implement risk-mitigation plans with respect to such shortages.</summary>
</bill>
